Liaropoulos L. and Goranitis I. Health care financing and the sustainability of health systems. International Journal for Equity in Health. 14:80 DOI 10.1186/s12939-015-0208-5
Frempong S., Goranitis I., and Oppong R. Economic evaluation alongside factorial trials: a systematic review of empirical studies. Expert Review of Pharmacoeconomics & Outcomes Research. (ahead-of-print), 1-11
Rachaneni S., McCooty S., Middleton L.J., Brookes V.L., Daniels J.P., Coomarasamy A., Verghese T., Balogun M., Goranitis I., Barton P., Roberts T.E., Deeks J.J., Latthe P. Accuracy and economic evaluation of Bladder Ultrasound in the diagnosis of Detrusor Overactivity: a study to evaluate if ultrasound can reduce the need for urodynamics. NIHR Health Technology Assessment (HTA). In Press
James N., Pirrie S., Pope A., Barton D., Andronis L., Goranitis I., Billingham L. et al. TRAPEZE: A randomised controlled trial of the clinical and cost effectiveness of chemotherapy with zoledronic acid, strontium-89 or both, in men with bony metastatic castrate refractory prostate cancer. NIHR Health Technology Assessment (HTA). In Press
Goranitis, I., Coast J., and Al-Janabi H.. An investigation into the construct validity of the Carer Experience Scale (CES). Quality of Life Research (2014): 1-10.
Goranitis, I., Siskou O., and Liaropoulos L. Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece. Health Policy 117.3 (2014): 279-284.
Goranitis, Ilias, Joanna Coast and Emma Frew. “Exploring alternative evaluative spaces and decision making principles in health economic evaluations: the case of treatment for heroin users.” Research paper presented at the International Health Economics Association. 12th to 15th July 2015. Hosted by the Bocconi University.
Goranitis, Ilias, Joanna Coast and Emma Frew. “Exploring the evaluative framework within economic evaluation: the case of treatment for heroin users.” Research paper presented at the Health Economists’ Study Group Meeting. 7th to 9th January 2015. Hosted by the Academic Unit of Health Economics at the University of Leeds.
James, Nick, Lazaros Andronis, Goranitis Ilias et al. “Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer. (ISRCTN 12808747) TRAPEZE.” Presented at 2015 American Society of Clinical Oncology (ASCO) Annual Meeting; J Clin Oncol 33, 2015 (suppl; abstr e16108)
Goranitis, Ilias and Emma Frew. “Health-related outcome and capability wellbeing: an exploration of the properties of ICECAP-A and EQ-5D-5L in the context of drug addiction.” Research paper presented at the Health Economists’ Study Group Meeting. 22nd to 24th June 2015. Hosted by the Health Economics Unit at the Lancaster University.